Bryan Andre Sandoval, RPH in Antonito, CO - Pharmacist

Bryan Andre Sandoval, RPH is a Pharmacist based in Antonito, Colorado. Bryan Andre Sandoval is licensed to practice in Colorado (license number 16713) and his current practice location is 327 Main, Antonito, Colorado. He can be reached at his office (for appointments etc.) via phone at (719) 376-5450.

NPI number for Bryan Andre Sandoval is 1447401963 and his current mailing address is 2801 Park Ave, Alamosa, Colorado. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1447401963.

Contact Information

	Bryan Andre Sandoval, RPH
	327 Main, Antonito, CO 81120
	(719) 376-5450
	Not Available

Healthcare Provider's Profile

Full Name	Bryan Andre Sandoval
Gender	Male
Speciality	Pharmacist
Location	327 Main, Antonito, Colorado
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1447401963
Provider Enumeration Date: 10/02/2008
Last Update Date: 10/02/2008

Medical Identifiers

Medical identifiers for Bryan Andre Sandoval such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1447401963	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	16713 (Colorado)	Primary
183500000X	Pharmacist	11224 (Nevada)	Secondary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Bryan Andre Sandoval is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Bryan Andre Sandoval, RPH 2801 Park Ave, Alamosa, CO 81101-2089 Ph: (719) 587-3885	Bryan Andre Sandoval, RPH 327 Main, Antonito, CO 81120 Ph: (719) 376-5450

News Archive

The Endocrine Society calls for nominations for Award for Excellence in Science and Medical Journalism

The Endocrine Society is calling for nominations for the fourth annual Award for Excellence in Science and Medical Journalism. The award recognizes outstanding reporting that enhances public understanding of health issues pertaining to the field of endocrinology.

RE-LY trial establishes effectiveness of PRADAX in reducing stroke risk in AF patients

Results of the landmark RE-LY(R) Trial (Randomized Evaluation of Long term anticoagulant therapy) demonstrate that atrial fibrillation (AF) patients taking PRADAX(R) (dabigatran etexilate) 150mg twice daily (BID) significantly reduced their risk of stroke and systemic embolism by 34 per cent (p less than 0.001) as compared to patients well-controlled on warfarin, without increasing the risk of major bleeding.

Mainz University Medical Center and Nagasaki University announce joint research into radiation epidemiology and biology

The University Medical Center of Johannes Gutenberg University Mainz and Nagasaki University in Japan plan to cooperate more closely in the future. At the focus of the partnership funded by the German Federal Ministry of Education and Research (BMBF) will be the joint development of a program of research into radiation epidemiology and radiation biology, the establishment of an exchange program for scientists and academics at the two universities, and, over the long term, the creation of a joint multicenter research project.

Questions surround how insurers are disclosing - or not - their 2015 proposed rates

News outlets from Florida and Iowa report on recent developments in these states. How much will it cost Floridians to buy coverage next year on Healthcare.gov? Lots of people want to know, but the insurers are keeping the prices secret in an unprecedented way (Gentry, 7/16).

Bryan Andre Sandoval, RPH - Pharmacist in Antonito, CO